Allegro Biotech
Regenerative Biomedical Technology
Regenerative Biomedical Technology
Allegro Biotech is a Belgium-based startup focusing on regenerative biomedical technology. Founded in 2021, the company specializes in designing and developing breakthrough biomedical nanotechnology for orthopedics, rheumatology, and regenerative medicine. In April 25, 2023, Allegro Biotech secured a significant milestone with a €5.50M Seed Round investment, with Noshaq and Annie Vereecken as the participating investors. With its innovative approach and promising developments in the vital field of biotechnology, Allegro is poised for expansion and potential growth in the market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €5.50M | 2 |
|
25 Apr 2023 |
| Pre Seed Round | €1.50M | 1 | KBC | 15 Dec 2021 |
No recent news or press coverage available for Allegro Biotech.
We care about your data, and we'd love to use cookies make your experience better.
